Home › Protocols › GH Triple Stack (CJC + Ipamorelin)
RESEARCH USE ONLY — This article describes a compound studied in laboratory and pre-clinical research. It is not intended for human or animal administration.

GH Triple Stack (CJC + Ipamorelin) Research Stack

Pulsatile GH amplification 3 compounds Reference duration: 8–12 weeks

Vault content pending — protocol scaffolded for production wiring.

Stack Rationale

The GH Triple Stack (CJC + Ipamorelin) combines 3 research compounds studied for pulsatile gh amplification. Detailed synergy rationale will populate from the Peptide Manager Pro knowledge base on the next vault sync.

Compound-by-Compound Review

cjc-1295

cjc-1295 — research reference page pending. See the research index.

Ipamorelin

Ipamorelin (Growth Hormone, half-life ~2 hours) — see the dedicated Ipamorelin research reference for mechanism, citations, and sourcing.

tesamorelin

tesamorelin — research reference page pending. See the research index.

Sample Research Protocols from the Literature

Published protocol references will be added during vault expansion.

Frequently Asked Questions

What is the GH Triple Stack (CJC + Ipamorelin) stack used for in research?

The GH Triple Stack (CJC + Ipamorelin) is a multi-compound research protocol studied in the context of pulsatile gh amplification. It is published here as a literature reference for laboratory researchers, not as clinical guidance.

Is the GH Triple Stack (CJC + Ipamorelin) stack safe for human or animal use?

Compounds in this stack are sold for in vitro and laboratory research only. They are not intended for human or veterinary administration, and no safety determination has been established for such use.

What is the typical research duration cited in the literature?

Published references for the GH Triple Stack (CJC + Ipamorelin) cite a research duration of 8–12 weeks. Full citation list will be added during the next vault expansion pass.